Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Sorrento Therapeutics, Inc. | srne-ex321_7.htm |
| EX-23.1 - EX-23.1 - Sorrento Therapeutics, Inc. | srne-ex231_8.htm |
| EX-31.2 - EX-31.2 - Sorrento Therapeutics, Inc. | srne-ex312_11.htm |
| EX-31.1 - EX-31.1 - Sorrento Therapeutics, Inc. | srne-ex311_12.htm |
| EX-10.26 - EX-10.26 - Sorrento Therapeutics, Inc. | srne-ex1026_396.htm |
| EX-10.27 - EX-10.27 - Sorrento Therapeutics, Inc. | srne-ex1027_748.htm |
| 10-K - 10-K - Sorrento Therapeutics, Inc. | srne-10k_20151231.htm |
Exhibit 21
Subsidiaries of Registrant
|
|
|
State of Jurisdiction of Organization |
|
Percentage of Voting Securities Owned |
|
|
|
Concortis Biosystems, Corp. |
|
Delaware |
|
|
100 |
% |
|
Sorrento Therapeutics, Inc. Hong Kong Limited |
|
Hong Kong, China |
|
|
100 |
% |
|
Ark Animal Health, Inc. |
|
Delaware |
|
|
100 |
% |
|
TNK Therapeutics, Inc. |
|
Delaware |
|
|
99 |
% |
|
LA Cell, Inc. |
|
Delaware |
|
|
64 |
% |
|
Sorrento Biologics, Inc. |
|
Delaware |
|
|
99 |
% |
|
Scintilla Pharmaceuticals, Inc. |
|
Delaware |
|
|
99 |
% |